NEW PRODUCT: Epidiolex for adjunctive treatment of seizuresGet the info you need on this new product, part of our drug news roundup for May. Goodbye spinal tap? A simple blood test to detect Alzheimer’s diseaseA study shows that a blood test can be as accurate as much more invasive, and expensive, tests in detecting Alzheimer's disease early. Antipsychotics associated with a wide range of adverse outcomes in dementia Risks of a broad range of adverse outcomes need to be considered before prescribing antipsychotic drugs for people with dementia. A mixed bag of supplement studies Vitamins for memory, probiotics for food allergies, magnesium for heart attack patients? Older adults’ brains ‘rewarded’ by music they don’t even like, B.C. researcher finds Sarah Faber said her work on how healthy brains respond to music as they age creates a baseline for future research on people who have Alzheimer’s or dementia to better understand those diseases. Your brain at work: Your occupation could impact your risk of cognitive impairment in later life Teacher, bookkeeper, mail carrier, doctor? Study suggests job type is associated with risk of cognitive decline after age 70. POP QUIZ: Nurtec ODT for migraine Can you figure out which statement about this newly approved treatment? Donepezil not associated with increased risk of proarrhythmic cardiac events Researchers say the finding could also help ease administrative burden for those prescribing this common medication for dementia. Is post-infectious myalgic encephalomyelitis due to ‘immune exhaustion’? Formerly called chronic fatigue syndrome, diagnosing post-infectious myalgic encephalomyelitis remains a challenge. Rimegepant (Nurtec ODT) now available for acute treatment of migraine Rimegepant is the second oral “gepant” for acute migraine to be marketed in Canada following ubrogepant (Ubrelvy). First Previous 10 11 12 13 14 Next Last
